LAB
Companies
NASDAQ
Standard Biotools Inc.
Health Care
$1.04
-$0.71 (-40.57%)
Price Chart
Overview
About LAB
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Market Cap
$858.2M
Volume
1.4M
Avg. Volume
2.1M
P/E Ratio
-5
Dividend Yield
0.00%
Employees
498.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.10
High Correlation
Volatility
High (0.86)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, LAB shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$858.2M
Volume1.4M
P/E Ratio-5.00
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025